Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reardon

Showing results (501-510 of 558) with videos related to

Pageof 56
Sort By:
The American Journal of Cardiology|September 4, 2017
Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United StatesTanush Gupta, Ankur Kalra, Dhaval Kolte, et al.
JACC. Cardiovascular Interventions|February 8, 2020
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI TrialNicolas M Van Mieghem, Jeffrey J Popma, G Michael Deeb, et al.
Genes & Development|July 3, 2004
Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transportOliver E Blacque, Michael J Reardon, Chunmei Li, et al.
Journal of the American College of Cardiology|September 19, 2015
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for SurgerySteven J Yakubov, David H Adams, Daniel R Watson, et al.
Journal of the American College of Cardiology|May 23, 2025
Valve Underexpansion and Clinical Outcomes With ACURATE neo2: Findings From the ACURATE IDE TrialRaj R Makkar, Tarun Chakravarty, Aakriti Gupta, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgeryStephen H Little, Jeffrey J Popma, Neal S Kleiman, et al.
European Heart Journal|January 20, 2023
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trialsYousif Ahmad, James P Howard, Ahran D Arnold, et al.
Journal of the American Heart Association|March 4, 2022
Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVTTsuyoshi Kaneko, Sreekanth Vemulapalli, Shun Kohsaka, et al.
Journal of the American College of Cardiology|March 25, 2014
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgeryJeffrey J Popma, David H Adams, Michael J Reardon, et al.
JACC. Cardiovascular Interventions|May 12, 2026
30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve DiseasePradeep K Yadav, Torsten P Vahl, Vinod H Thourani, et al.
Pageof 56

Showing results (501-510 of 558) with videos related to

Sort By:
Pageof 56
The American Journal of Cardiology|September 4, 2017
Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United StatesTanush Gupta, Ankur Kalra, Dhaval Kolte, et al.
JACC. Cardiovascular Interventions|February 8, 2020
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI TrialNicolas M Van Mieghem, Jeffrey J Popma, G Michael Deeb, et al.
Genes & Development|July 3, 2004
Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transportOliver E Blacque, Michael J Reardon, Chunmei Li, et al.
Journal of the American College of Cardiology|September 19, 2015
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for SurgerySteven J Yakubov, David H Adams, Daniel R Watson, et al.
Journal of the American College of Cardiology|May 23, 2025
Valve Underexpansion and Clinical Outcomes With ACURATE neo2: Findings From the ACURATE IDE TrialRaj R Makkar, Tarun Chakravarty, Aakriti Gupta, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgeryStephen H Little, Jeffrey J Popma, Neal S Kleiman, et al.
European Heart Journal|January 20, 2023
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trialsYousif Ahmad, James P Howard, Ahran D Arnold, et al.
Journal of the American Heart Association|March 4, 2022
Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVTTsuyoshi Kaneko, Sreekanth Vemulapalli, Shun Kohsaka, et al.
Journal of the American College of Cardiology|March 25, 2014
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgeryJeffrey J Popma, David H Adams, Michael J Reardon, et al.
JACC. Cardiovascular Interventions|May 12, 2026
30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve DiseasePradeep K Yadav, Torsten P Vahl, Vinod H Thourani, et al.
Pageof 56